YING YUAN to Lung Neoplasms
This is a "connection" page, showing publications YING YUAN has written about Lung Neoplasms.
Connection Strength
0.154
-
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. J Immunother Cancer. 2024 Feb 02; 12(2).
Score: 0.049
-
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol. 2021 09; 162:60-67.
Score: 0.041
-
Assessment of a quantitative metric for 4D CT artifact evaluation by observer consensus. J Appl Clin Med Phys. 2014 May 08; 15(3):4718.
Score: 0.025
-
Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets. PLoS One. 2012; 7(9):e45894.
Score: 0.022
-
Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update. Clin Trials. 2019 12; 16(6):645-656.
Score: 0.009
-
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. Cancer Res. 2017 07 15; 77(14):3894-3907.
Score: 0.008